Beam Therapeutics Inc. Share Price

Beam Therapeutics Inc. Share Price

NASDAQ: BEAM | Mid Cap
$29.26
+$0.44 (1.53%) Last updated on 29 Oct, 2026 | 20:38 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Beam Therapeutics Inc. Stock Performance

Open
$29.12
Prev. Close
$28.82
Circuit Range
N/A
Day Range
$28.95 - $29.65
Year Range
$20.23 - $38.16
Volume
26,206
Average Traded
$29.22

Beam Therapeutics Inc. Share Price Today

As of 29 October 2026, Beam Therapeutics Inc.'s share price is $29.26. The stock opened at $29.12, compared to its previous close of $28.82. During today's trading session, Beam Therapeutics Inc.'s share price traded between $28.95 and $29.65, with an average price of $29.30. Over the past 52 weeks, the stock has recorded a high of $38.16 and a low of $20.23. In terms of performance, Beam Therapeutics Inc.'s share price has declined by 3.46% over the last six months and is up 16.99% on a year-on-year basis.

Beam Therapeutics Inc. Share Price Chart

Line chart of the Beam Therapeutics Inc. price trend over the selected period. The price rose overall, ranging from 28.95 to 29.72, ending at 29.26.
$28.95$29.65
L
Show Current Price
H

Beam Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.89B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.83
Revenue (TTM)
$139.74B
Return On Equity (TTM)
-8.00%
Profit Margin
-57.24%
Debt to Equity
0.09
Quarterly Earnings Growth YoY
-8.83%

Beam Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$9.70$114.11$31.74$0.49
Net Profit-$112.73$244.30-$94.32-$122.68
Net Profit Margin-1162.16%214.09%-297.16%-25036.73%
Income ChangeN/A316.71%-138.61%-30.07%

Beam Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$60.92$377.71$63.52$139.74
Net Profit-$289.09-$132.53-$376.74-$79.99
Net Profit Margin-474.54%-35.09%-593.10%-57.24%
Income ChangeN/A54.16%-184.27%78.77%

About Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Beam Therapeutics Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$23.97
$29.24
+19.40%
Sep 2026
$29.02
$24.49
-19.55%
Aug 2026
$25.55
$30.44
+19.42%
Jul 2026
$34.67
$25.49
-25.69%
Jun 2026
$32.31
$34.30
+4.13%
May 2026
$29.93
$32.94
+8.68%
Apr 2026
$24.35
$30.31
+27.27%
Mar 2026
$27.50
$23.82
-16.38%
Feb 2026
$27.24
$28.48
+3.15%
Jan 2026
$27.63
$27.61
-0.36%
Dec 2025
$24.91
$27.71
+9.37%
Nov 2025
$24.98
$25.34
+1.30%

BEAM Share Price FAQs